71-year-old man with chronic kidney failure and sudden change of mental status.
Mansfield
Aaron S
AS
Mayo School of Graduate Medical Education, Rochester, MN 55905, USA.
Qian
Qi
Q
D000046:Academic Medical Centers; D000368:Aged; D000588:Amines / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D000700:Analgesics / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D003221:Confusion / Q000139:chemically induced / Q000503:physiopathology; D003509:Cyclohexanecarboxylic Acids / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D000077206:Gabapentin; D006801:Humans; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000628:therapy*; D007677:Kidney Function Tests; D008297:Male; D001523:Mental Disorders / Q000139:chemically induced* / Q000503:physiopathology; D008910:Minnesota; D006435:Renal Dialysis / Q000009:adverse effects / Q000379:methods*; D018570:Risk Assessment; D028761:Withholding Treatment; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use
D000588:Amines; D000700:Analgesics; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin